RAHMI ASLAN et al. RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy. Turkish Journal of Gastroenterology, [S. l.], v. 34, n. 3, p. 310–310, 2023. Disponível em: https://tjg.avesjournals.com/index.php/tjg/article/view/4414. Acesso em: 16 jul. 2025.